Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09KWN
|
|||
Drug Name |
Anti-MUC1 CAR-T cells
|
|||
Drug Type |
CAR T Cell Therapy
|
|||
Indication | Esophageal cancer [ICD-11: 2B70] | Phase 1/2 | [1] | |
Company |
The First Affiliated Hospital of Guangdong Pharmaceutical University
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Mucin-1 (MUC1) | Target Info | CAR-T-Cell-Therapy | [1] |
WikiPathways | Hematopoietic Stem Cell Differentiation |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03706326) CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.